News
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that the Phase 3 clinical trial assessing the safety and efficacy of EXPAREL(R) (bupivacaine liposome injectable suspension) in femoral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback